Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study.

Frontiers in immunology - 1 Jan 2021

Hou Haifeng, Yang Huan, Liu Pengcheng, Huang Changwu, Wang Meng, Li Yuejin, Zhu Mingsong, Wang Jing, Xu Yuan, Wang Youxin, Ma Qingwei, Li Dong, Liao Pu, Wang Wei

Abstract excerpt

Coronavirus disease 2019 (COVID-19) remains a major health challenge globally. Previous studies have suggested that changes in the glycosylation of IgG are closely associated with the severity of COVID-19. This study aimed to compare the profiles of IgG N-glycome between COVID-19 patients and healthy controls. A case-control study was conducted, in which 104 COVID-19 patients and 104 age- and sex-matched healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibody-Dependent Cell Cytotoxicity
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromatography, High Pressure Liquid

Share to COVID-19

Share to Glycosylation

Share to Immunoglobulin G

Share to Phenotype

Share to SARS-CoV-2

Source

Open in PubMed Open full text

Identifiers

PMID: 34630427
DOI: 10.3389/fimmu.2021.748566
PMCID: PMC8495247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profile of Immunoglobulin G N-Glycome in COVID-19 Patients: A Case-Control Study.PMID 34630427Read ↗

Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19Semantic proximity Read ↗

Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19Semantic proximity Read ↗

IgG N-glycan Signatures as Potential Diagnostic and Prognostic BiomarkersSemantic proximity Read ↗

Global variability of the human IgG glycomeSemantic proximity Read ↗

The COVID-19 antibody responses, isotypes and glycosylation: Why SARS-CoV-2 Spike protein complex binding of IgG3 is potentiated in some and immuno-pathologies manifestSemantic proximity Read ↗

Immunoglobulin G glycosylation in aging and diseasesSemantic proximity Read ↗

Global variability of the human IgG glycomeSemantic proximity Read ↗

Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics PerspectiveSemantic proximity Read ↗

Immunoglobulin G glycosylation and its alterations in aging-related diseasesSemantic proximity Read ↗

Unravelling Immunoglobulin G Fc N-Glycosylation: A Dynamic Marker Potentiating Predictive, Preventive and Personalised MedicineSemantic proximity Read ↗

Differential Peripheral Blood Glycoprotein Profiles in Symptomatic and Asymptomatic COVID-19Semantic proximity Read ↗

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector ActivitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.